It is finally time for BioVentureHubs annual summer update. Please be part of our journey by digging into this edition. It is all about what we all care about, the future, the past, fantastic collaborations, change and growth... But mostly we think it brings hope... simply because we do everything together. Hope for a more sustainable future in our joint strive to actually contribute to what it´s all about - people, society and planet. To be able to do this we are taking some time of now, to relax and recharging a little, and come back later with extra energy. We wish you a wonderful season and look forward to connecting with you soon. Thank you all for good collaboration. Enjoy summer Click here for your update https://lnkd.in/dxykKKHn #summer #update #relax #recharge #enjoy The BioVentureHub team - extended version... Magnus R. Björsne, PhD, MBA, Assoc. Prof., Ulrika Edvardsson, Pernilla Isberg, Robert Roth, Emma Wiesel, Robert Börjes, Erica Woodrow, Anders Persson, Alexander Kvist, Daniel Johansson
BioVentureHub
Forskning inom bioteknik
"One of the most novel incubators in the world" - The Medici Group (Dec. 2018)
Om oss
AstraZeneca BioVentureHub is a not-for-profit, open innovation hub offering an inside track to AstraZeneca's scientific expertise and world-class infrastructure and facilities. Integrated at the heart of AstraZeneca ́s strategic R&D centre in Gothenburg, Sweden, the BioVentureHub enables emerging life science companies and academia to work in close proximity to AstraZeneca experts and to learn from each other, within our focus areas - BioTech, HealthTech and SustainTech. Our dare-to-share culture, trust and scientific curiosity are at the core of being part of the BioVentureHub. We believe in Growing Innovation Together. What do you believe in?
- Webbplats
-
http://www.azbioventurehub.com
Extern länk för BioVentureHub
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 2–10 anställda
- Typ
- Privatägt företag
- Grundat
- 2014
- Specialistområden
- Life science, Drugs, Devices, Diagnostics, Digital health, Innovation, Collaboration och MedTech
Adresser
-
Primär
Pepparedsleden
-
Gothenburg, SE
Uppdateringar
-
OK! Soon weekend. We know. Many people are busy, planning summer vacation and will eventually think about if it really matters, all efforts we put in everyday in our work? We think it does! This is a good example of what impact teamwork and collaboration can do. Thank you Martin Olovsson and the OnDosis team for being such a good example. Really inspiring to watch your journey over the years. At AstraZeneca, BioVentureHub and now at GoCo Health Innovation City. Enjoy the impact story, and a little hint... don´t miss the video in the end of the reading. We wish you good reading and a nice weekend. Stay tuned... more will come.... #Collaboration #Impact #Story #Growing #Innovation #Together #OnDosis #Infrastructure #Expertise #Access https://lnkd.in/dsMpR4-N
-
The collaboration goes on. Looking forward to the continuous outcome. Watch this and stay tuned! #NewModalities #Collaboration #GUV
🚀 New Website Launch! 🚀 New Modality Support (NMS) — a collaboration between Sahlgrenska Academy at University of Gothenburg, Sahlgrenska Universitetssjukhuset and GU Ventures, was established recently, with the mission to support the commercial development of research projects within the national drug development initiatives OligoNova Hub and CCRM Nordic. We’re excited to announce the launch of our brand-new website: https://lnkd.in/dKa2U2vi Check out our landing page in the video below and visit us for the full experience. Explore our focus areas and future plans by browsing through our pages. We feature our constellation members and a selection of esteemed collaborators. Thank you for your support; we look forward to continuing our work together! BioVentureHub, ATMP Sweden, CCRM, FUHS - Föreningen Universitetsholdingbolag i Sverige, GoCo Health Innovation City, Invest in Gothenburg, Lif - de forskande läkemedelsföretagen (The Swedish Association of the Pharmaceutical Industry LIF), NorthX Biologics, SciLifeLab, SciLifeLab Drug Discovery & Development, SwedenBIO, Testa Center, Västra Götalandsregionen, WCMTM University of Gothenburg
-
We look back with joy on the truly exciting days we spent in Oslo last week, to follow up the collaboration between AstraZeneca BioVentureHub, Oslo Cancer Cluster, and Oslo Science City, which was kicked off earlier this year. We had the invaluable opportunity to take part at the Norway Health Tech Festival and the Oslo Cancer Cluster summer gathering, in addition to aligning our initiatives, discussing the future, and establishing new connections with our partners, ecosystem players, and innovative companies. A heartfelt thank you to Guro Bjøntegaard and the AstraZeneca Norway team for meticulously planning and orchestrating a meeting that included everything we needed in fostering collaboration and innovation. We are excited about the future and look forward to continuing our work together to make a meaningful impact. #Growing #Innovation #Together #OCC #OSC #BioVentureHub #Norway #Ecosystem #Collaboration Guro Bjøntegaard, Christine Wergeland Sørbye, Ketil F. Widerberg, Ulrika Edvardsson, Robert Roth
-
A new, exciting strategic collaboration and partnership has been established. Boubou Hallberg Hospital Director at Sahlgrenska Universitetssjukhuset says "The strategic partnership enhances our efforts to become a leading university hospital in Europe. Sahlgrenska University Hospital has long collaborated with AstraZeneca in research and innovation. Now, we are taking the next step together. The results of this collaboration will benefit our patients and the entire life science sector". "AstraZeneca always puts the patient first. Therefore, it is extremely gratifying that we are now initiating a collaboration with Sahlgrenska University Hospital, where we can together strengthen both healthcare and the development of new drugs", Anders Persson, Head of Ecosystem Strategy & Projects, BioVenture Innovation Unit, AstraZeneca says. Or as Regina Fritsche Danielson, Senior VP and Site Lead AstraZeneca R&D Gothenburg, puts it: "To enable quicker access for patients to novel therapeutics, a close collaboration between industry and hospitals are key. I am super-excited about this new collaboration between AstraZeneca and Sahlgrenska University Hospital". Many thanks to involved for great collaboration around this strategic partnership between AstraZeneca and Sahlgrenska Universitetssjukhuset, in Gothenburg, for the benefit of patients in Europe and the world. A true evidence of the innovative culture in Gothenburg. Please follow the link to the press-release (in Swedish) to learn more. #Collaboration #PatientsFirst #Sahlgrenska #AstraZeneca #ResourceExchange #Knowledgetransfer #ClinicalTrials #Education #Growing #Innovation #Together #Gothenburg #HealthCare
I dag har vi glädjen att kunna berätta om ett nytt och viktigt samarbete mellan Sahlgrenska University Hospital och AstraZeneca för att ytterligare stärka life science-sektorn, i Västsverige och hela landet. Partnerskapet ska främja utvecklingen av innovativa läkemedel och göra dem tillgängliga snabbare för patienterna. Inledningsvis kommer tre samarbetsområden att stå i fokus: Personalutbyte, stöd till kliniska prövningar och utbildning. - Det är oerhört glädjande att vi nu inleder det här samarbetet med Sahlgrenska Universitetssjukhuset, där vi tillsammans kan stärka både vården och utvecklingen av nya läkemedel, säger Regina Fritsche Danielson, global chef för forskning och tidig utveckling inom kardiovaskulära, njur- och metabola sjukdomar på AstraZeneca, och site lead på forskningsanläggningen i Göteborg. Läs mer om samarbetet i pressmeddelandet från Sahlgrenska Universitetssjukhuset: https://lnkd.in/dJ-BFH_6
-
We wish the Cereno Scientific team a successful start to the new phase of their journey, growing out of AstraZeneca BioVentureHub, moving into the local and vibrant ecosystem of GoCo Health Innovation City. Founded in 2012 with support from GU Ventures, Cereno has evolved from a young biotech listed on the Spotlight Stock Market in 2016 to a thriving billion SEK company, with a phase II candidate. After uplisting to Nasdaq First North Growth Market in 2023 and raising over 500 MSEK in capital, Cereno engaged in successful joint ventures with other BioVentureHub companies, positioning itself for further growth. We thank Sten R. Sörensen, Fredrik Frick, PhD, Julia Fransson, Henrik Westdahl and the Cereno team for the fruitful years we've spent together, and are looking forward to see you participating in our BioVentureHub alumni activities at GoCo Health Innovation City, connecting and collaborating with other rapidly expanding life science firms. We don't say goodbye - we say arrivederci. #Cereno #GrowingOut #BioVentureHub #MovingIn #GoCoHIC #Nasdaq #Collaboration #Arrivederci #Alumni
Cereno Scientific moves to new office space at GoCo Health Innovation City in Gothenburg Cereno is moving to a new office space at GoCo Health Innovation City in Gothenburg in June 2024. The re-location to GoCo’s inspiring community will support the further propelling of Cereno’s pipeline and the next step of the Company’s growth journey. Read the full press release here:
Read the press release
news.cision.com
-
BioVentureHub is proud to collaborate with AstraZeneca and My Green Lab to extend the AstraZeneca Green Lab certification program to our lab companies. Through this unique and customized initiative, BioVentureHub companies are gaining valuable insights into sustainable lab practices and discovering innovative ways to reduce their environmental impact. ♻️ By sharing our ongoing work and practical examples, we aim to inspire others to take meaningful action towards sustainability. 🌱👉 Special thanks to OligoNova Hub and Simsen Diagnostics for their great contributions. Pernilla Sörme Kristina Flisberg Hanna Tranchell Lina Said My Vu Lars Thelin Nitai Agnon Pernilla Isberg Ulrika Edvardsson Robert Börjes Robert Roth Emma Wiesel Magnus R. Björsne, PhD, MBA, Assoc. Prof. Erica Woodrow #BioVentureHub #AstraZeneca #MyGreenLab #Sustainability
-
BioVentureHub omdelade detta
The Future of Life Science Symposium and the theme was creeping crises. Topics such as the pandemic, microbial resistance, and climate change all characterize happenings where it is just a matter of time, we kind of know it... Given all opportunities that actually exists and where we can come together in order to be more proactive, yet another creeping crise springs to mind - our collective inability to act upon opportunities. In this interview I got the opportunity to provide my reflections on a very interesting symposia arranged by Stockholm Science City. Enjoy. #bioventurehub #innovation #astrazeneca #stockholmsciencecity #opportunity #ssci
Lärdomar från symposiet The Future of Life Science
ssci.se
-
Thank you all for visiting the AstraZeneca exhibition at GoCo Open House the 29th. More than 600 life science enthusiasts came and the tenants, founders and partners, showcased their work in the long avenue, in their offices, on local tours, and on stage. The AstraZeneca site team, along with AstraZeneca R&D IT, presented a true reality live arena, demonstrating Augmented Reality, Virtual Reality, and other solutions from "Digital Lab," "Snake Study," and "Research Assistant." Additionally, the AstraZeneca BioVenture Innovation Unit team and BioVentureHub showcased innovation management thinking and discussed future collaborative possibilities, providing a compressed overview of our R&D site activities and our role as a founding partner in the local ecosystem, as well as the Swedish and Nordic ecosystem. Being situated with our exhibition area on the first floor and encouraging people to take the stairs was actually not bad at all. It allowed for meaningful conversations and relationship building in a calm and relaxed environment. Not only did we take care of our visitors, but Daniel Johansson from AstraZeneca BioVenture Innovation Unit also brought vibrancy and good energy to the opening panel discussion on "Powering Innovation Culture," alongside panelist Guillaume Cabrère, Volvo Cars, Julia Grönros Ribocure Pharmaceuticals AB, and Klementina Österberg (fd Jozsa),GU Ventures. Nicely moderated by Viktor Bakker, GoCo Health Innovation City. For those of you who were able to attend – thank you, it was great to see you. For the rest of you – see you next time. Have a nice weekend, everyone! 😀 🌞 😎 #Growing #Innovation #Together #GoCoHIC #BioVentureHub #Ecosystem #Collaboration #VR #MR #XR #LiveRealityArena #LifeScience Founding Partners: AstraZeneca, Chalmers tekniska högskola,Fujirebio Diagnostics AB, Sahlgrenska Academy at University of Gothenburg, Mölnlycke Health Care, Wellspect HealthCare Emma Wiesel, Malin Toftefors, Josefine Johansson, Johanna Kollback, Hampus Andersson, Pernilla Isberg, Robert Roth, Robert Börjes, Alexander Kvist, Anders Persson, Magnus R. Björsne, PhD, MBA, Assoc. Prof., Erica Woodrow, Victoria Leijon, Jessica Martinsson, Moa Dicksdotter Anders Fogelberg, Profundus AB, Magnus Larsson, Martin Olovsson, OnDosis, Philip Chaabane, I-Tech AB, Developers of Selektope®
-
+3
-
Proud, but not surprised that Nyctea Technologies, a AstraZeneca BioVentureHub company, have been named as one of twenty Life Science companies to the BioTools Innovator annual cohort, 4 month accelerator program. They are one of three from European Union, and the only company from Sweden. A big congrats to Gustav Ferrand-Drake and the Nyctea Technologies team, as well as our innovation partners Chalmers Ventures, for hosting and supporting them in the earlier phase, as well as their collaborative AstraZeneca scientists, at the R&D site in Gothenburg. Looking forward to running positive reports when we meet in the corridors or at our nurturing events! Well done and Good Luck! #Growing #Innovation #Together #Nyctea #Biopharmaceutical #Purification #SustainTech #Proximity #Science #Infrastructure #Gothenburg #LifeScienceCluster #BioVentureHub #InCollaboration #DareToShare #Culture Maria Kiriakidou, Hanna Tranchell, Oliver Olsson, Armaghan R., Christine Ellis, Andreas Dahlin, Susanna Abrahmsén Alami, Pontus Ottosson, Ulrika Edvardsson, Pernilla Isberg, Robert Roth, Robert Börjes, Emma Wiesel
🥁 We are excited to announce the 2024 BioTools Innovator cohort featuring 20 innovative companies dedicated to revolutionizing the biotech landscape! 🙌 Thrilled to introduce these trailblazers to our ecosystem of partners, strategics, and industry leaders throughout our accelerator program. Check out the new tech and cutting edge solutions from our cohort companies in the official press release here✨: https://lnkd.in/giF4HCi4 #iamaninnovator #biotech #techbio #bti #diagnostics #biotools #lifesciencetools